BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 7147918)

  • 1. [Viral hepatitis associated with prolonged hemodialysis treatment].
    Kiriakov Z; Patev E; Todorov K; Simeonov P; Dimitrova T
    Vutr Boles; 1982; 21(4):41-6. PubMed ID: 7147918
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Investigation of hemodialysis patients in terms of the presence of occult hepatitis B].
    Altindiş M; Uslan I; Cetinkaya Z; Yüksel S; Ciftçi IH; Demirtürk N; Ozdemir M; Arslan F; Aktepe OC
    Mikrobiyol Bul; 2007 Apr; 41(2):227-33. PubMed ID: 17682709
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hepatitis B virus markers among family contacts and medical personnel of 239 hemodialysis patients.
    Gahl GM; Vogl E; Kraft D; Hess G; Arnold W
    Clin Nephrol; 1980 Jul; 14(1):8-12. PubMed ID: 7408256
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Surface antigen (HBsAg) and core antibody (anti-HBc) in chronic uremia during periodic hemodialysis treatment of hepatitis B patients. Correlation with viral replication markers (HBeAg and DNA polymerase activity)].
    Buongiorno R; Dentico P; Santantonio T; Frappampina V; Spinelli A; Amato M; Pastore G
    Boll Soc Ital Biol Sper; 1980 Oct; 56(20):2076-82. PubMed ID: 7459119
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatitis B vaccine as a cause of false positive hepatitis B surface antigen.
    Olde C; Garcia M
    J CANNT; 1998; 8(4):20-1. PubMed ID: 10196927
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hepatitis B virus infection in hemodialysis: recent discoveries.
    Fabrizi F; Lunghi G; Martin P
    J Nephrol; 2002; 15(5):463-8. PubMed ID: 12455711
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Infections with hepatitis B virus in hemodialysis units of Wielkopolska].
    Grzegorzewska AE; Kurzawska-Firlej D; Swiderski A; de Mezer-Dambek M; Frankiewicz D; Zaremba-Drobnik D; Banachowicz W; Dumanowska-Zmuda A; Ratajewski W; Niepolski L; Krawczyk R; Sobolewski J; Pulchny J; Molenda J; Wojciechowski J; Mikstacki Z; Zachwieja J
    Przegl Epidemiol; 2008; 62(1):29-37. PubMed ID: 18536222
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence of occult hepatitis B and hepatitis C virus infections in Turkish hemodialysis patients.
    Yakaryilmaz F; Gurbuz OA; Guliter S; Mert A; Songur Y; Karakan T; Keles H
    Ren Fail; 2006; 28(8):729-35. PubMed ID: 17162434
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Prevention and treatment of hepatitis B in patients on hemodialysis and vaccination of hemodialysis health personnel against hepatitis B].
    Kes P; Slavicek J; Janković N
    Acta Med Croatica; 2005; 59(5):479-82. PubMed ID: 16381247
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hepatitis B infection among patients receiving chronic hemodialysis at the Royal Medical Services in Jordan.
    Al Hijazat M; Ajlouni YM
    Saudi J Kidney Dis Transpl; 2008 Mar; 19(2):260-7. PubMed ID: 18310881
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Early diagnosis and characteristics of the course of HBsAg-positive and HBsAg-negative chronic persistent hepatitis].
    Dzhumabaev TZ
    Klin Med (Mosk); 1989 Feb; 67(2):73-5. PubMed ID: 2724893
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Molecular biology and serologic analysis in an epidemic of viral hepatitis B in vaccinated patients on hemodialysis].
    Nĕmecek V; Reinis M; Konopácová A; Summerová M; König J; Kubánek J
    Epidemiol Mikrobiol Imunol; 1999 Nov; 48(4):160-6. PubMed ID: 10658344
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hepatitis B virus infection in Thai hemodialysis patients.
    Phanichphant S; Mekswasdi P; Charuvichitratana J
    Southeast Asian J Trop Med Public Health; 1985 Jun; 16(2):280-4. PubMed ID: 4071201
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hepatitis in the Auckland dialysis unit.
    Bowie EA; Doak PB; North JD
    N Z Med J; 1973 Feb; 77(489):75-80. PubMed ID: 4573132
    [No Abstract]   [Full Text] [Related]  

  • 15. National surveillance of dialysis associated diseases in the United States, 1993.
    Tokars JI; Alter MJ; Favero MS; Moyer LA; Miller E; Bland LA
    ASAIO J; 1996; 42(3):219-29. PubMed ID: 8725695
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hepatitis B virus infection in allogeneic bone marrow transplantation.
    Ustün C; Koç H; Karayalcin S; Akyol G; Gürman G; Ilhan O; Akan H; Ozcan M; Arslan O; Konuk N; Uysal A; Beksaç M
    Bone Marrow Transplant; 1997 Aug; 20(4):289-96. PubMed ID: 9285543
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An epidemic of hepatitis in a renal dialysis unit.
    Fox RA; Knight AH; Niazi SP; Sherlock S; Baillod RA; Moorhead JF
    Proc R Soc Med; 1971 Mar; 64(3):277-8. PubMed ID: 4994581
    [No Abstract]   [Full Text] [Related]  

  • 18. Low HBV-DNA levels in end-stage renal disease patients with HBeAg-negative chronic hepatitis B.
    Moutinho RS; Perez RM; Medina-Pestana JO; Figueiredo MS; Koide S; Alberto FL; Silva AE; Ferraz ML
    J Med Virol; 2006 Oct; 78(10):1284-8. PubMed ID: 16927290
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multiple hepatitis B virus markers in dialysis patients.
    Acchiardo S; Cockrell S
    Trans Am Soc Artif Intern Organs; 1982; 28():308-11. PubMed ID: 7164253
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The spread of viral hepatitis in Italian dialysis units.
    Piccinino F; Giusti G
    Acta Hepatogastroenterol (Stuttg); 1976; 23(6):392-8. PubMed ID: 1007825
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.